ES2077530B1 - Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. - Google Patents

Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.

Info

Publication number
ES2077530B1
ES2077530B1 ES09350011A ES9350011A ES2077530B1 ES 2077530 B1 ES2077530 B1 ES 2077530B1 ES 09350011 A ES09350011 A ES 09350011A ES 9350011 A ES9350011 A ES 9350011A ES 2077530 B1 ES2077530 B1 ES 2077530B1
Authority
ES
Spain
Prior art keywords
procedure
preparation
pharmaceutical products
tumor diseases
cure tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09350011A
Other languages
English (en)
Other versions
ES2077530A1 (es
Inventor
G Bor Somlyai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HYD Kutato-Fejleszto Kft
Original Assignee
HYD Kutato-Fejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HYD Kutato-Fejleszto Kft filed Critical HYD Kutato-Fejleszto Kft
Publication of ES2077530A1 publication Critical patent/ES2077530A1/es
Application granted granted Critical
Publication of ES2077530B1 publication Critical patent/ES2077530B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE PRODUCTOS FARMACEUTICOS PARA CURAR ENFERMEDADES TUMORALES. LA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE PRODUCTOS PARA CURAR ENFERMEDADES TUMORALES QUE INCLUYEN COMO AGENTE ACTIVO AGUA O SOLUCIONES ACUOSAS, SON APROPIADOS PARA EL CONSUMO HUMANO, TIENEN UN CONTENIDO DE DEUTERIO COMPRENDIDO ENTRE 0,1 Y 110 PPM, OPCIONALMENTE JUNTO CON PORTADORES Y/O SUSTANCIAS AUXILIARES, Y ADOPTAN LA FORMA DE PRODUCTOS FARMACEUTICOS O SOLUCIONES MEDICINALES.
ES09350011A 1991-10-31 1992-09-28 Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. Expired - Fee Related ES2077530B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases

Publications (2)

Publication Number Publication Date
ES2077530A1 ES2077530A1 (es) 1995-11-16
ES2077530B1 true ES2077530B1 (es) 1996-07-01

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09350011A Expired - Fee Related ES2077530B1 (es) 1991-10-31 1992-09-28 Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.

Country Status (22)

Country Link
US (1) US5855921A (es)
JP (1) JP3569916B2 (es)
KR (1) KR100253874B1 (es)
CN (1) CN1045162C (es)
AT (1) AT402692B (es)
BE (1) BE1006186A3 (es)
CA (1) CA2122612C (es)
CH (1) CH685282A5 (es)
CZ (1) CZ282379B6 (es)
DE (1) DE4232465B4 (es)
DK (1) DK170832B1 (es)
ES (1) ES2077530B1 (es)
FI (1) FI114010B (es)
FR (1) FR2683148B1 (es)
GB (1) GB2276086B (es)
HU (1) HU208084B (es)
IT (1) IT1255390B (es)
LU (1) LU88175A1 (es)
NL (1) NL194664C (es)
NO (1) NO307031B1 (es)
SE (1) SE513624C2 (es)
WO (1) WO1993008794A1 (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018545A1 (en) * 1994-01-06 1995-07-13 Hyd Kutató-Fejlesztó Ktf. Food products for preventing development of diseases and process for preparing same
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
WO2003068919A2 (en) * 2002-02-12 2003-08-21 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
WO2004011426A2 (en) 2002-07-30 2004-02-05 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
US7255850B2 (en) * 2002-09-13 2007-08-14 The Regents Of The University Of California Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
CA2504313C (en) 2002-11-04 2012-01-17 Marc K. Hellerstein Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
AU2005327332B2 (en) 2005-02-08 2010-07-22 Woodford Associates Limited Non-alcoholic beverage enriched with 1H216O
ATE505532T1 (de) * 2005-02-08 2011-04-15 Woodford Associates Ltd Mit 1h2160 angereichertes alkoholisches getränk
KR100928384B1 (ko) * 2005-03-05 2009-11-23 세르게이 파브로비치 솔로비에프 1h216o가 강화된 화장품 조성물
EA012855B1 (ru) * 2005-03-11 2009-12-30 Вада Консалтинг Лимитед Легкая фармацевтическая вода, терапевтические композиции, ее содержащие, способы их производства и применения
JP2008533005A (ja) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド 生物学的活性物質の皮内的、経皮的又は経粘膜的送達のための方法
CN101146448A (zh) * 2005-03-11 2008-03-19 维达咨询有限公司 用于消毒无生命表面的组合物
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
EP1971350A1 (en) * 2005-12-12 2008-09-24 VADA Consulting Limited Method of treating metabolic syndrome
US20080292718A1 (en) * 2005-12-12 2008-11-27 Igor Anatolievich Pomytkin Method for Suppression Appetite and Food Intake
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE202009018629U1 (de) 2009-04-21 2012-06-11 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
ES2650223T3 (es) * 2011-05-27 2018-01-17 Bristol-Myers Squibb Company Tripéptidos que incorporan deuterio como inhibidores del virus de la hepatitis C
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
US20140353486A1 (en) 2011-12-07 2014-12-04 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
US20150374745A1 (en) * 2014-06-30 2015-12-31 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
AU2017329108B2 (en) * 2016-09-21 2022-07-07 Botanical Water Technologies Ip Ltd Isotopic compositions
JP7262480B2 (ja) * 2018-01-02 2023-04-21 ボタニカル ウォーター テクノロジーズ アイピー リミテッド 同位体組成物
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
CA2122612A1 (en) 1993-05-13
ES2077530A1 (es) 1995-11-16
DE4232465B4 (de) 2008-11-06
SE9401406D0 (sv) 1994-04-25
NL9220026A (nl) 1994-09-01
WO1993008794A1 (en) 1993-05-13
DK170832B1 (da) 1996-02-05
ITMI922233A1 (it) 1994-03-28
LU88175A1 (fr) 1993-03-15
HU913437D0 (en) 1992-01-28
FR2683148A1 (fr) 1993-05-07
NO941590L (es) 1994-06-23
SE513624C2 (sv) 2000-10-09
NO941590D0 (es) 1994-04-29
NL194664C (nl) 2002-11-04
IT1255390B (it) 1995-10-31
AT402692B (de) 1997-07-25
CH685282A5 (de) 1995-05-31
CN1071836A (zh) 1993-05-12
DE4232465A1 (de) 1993-05-06
JPH08501275A (ja) 1996-02-13
BE1006186A3 (fr) 1994-06-07
CA2122612C (en) 2003-02-04
ATA902992A (de) 1996-12-15
ITMI922233A0 (it) 1992-09-28
SE9401406L (sv) 1994-06-07
GB9408654D0 (en) 1994-07-20
GB2276086B (en) 1995-09-27
KR100253874B1 (ko) 2000-04-15
JP3569916B2 (ja) 2004-09-29
FI114010B (fi) 2004-07-30
NO307031B1 (no) 2000-01-31
US5855921A (en) 1999-01-05
FI941979A (fi) 1994-06-29
CZ102094A3 (en) 1994-12-15
CN1045162C (zh) 1999-09-22
CZ282379B6 (cs) 1997-07-16
FI941979A0 (fi) 1994-04-29
HU208084B (en) 1993-08-30
FR2683148B1 (fr) 1994-09-09
GB2276086A (en) 1994-09-21
NL194664B (nl) 2002-07-01
KR930007461A (ko) 1993-05-20

Similar Documents

Publication Publication Date Title
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ES2074124T5 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
CY1110376T1 (el) Χρηση μιας συνθεσης που περιλαμβανει φορμοτερολη και βουδεσονιδη για την προληψη απο ή τη θεραπευτικη αντιμετωπιση μιας οξειας καταστασης ασθματος
AR029716A1 (es) Productos dermatologicos en forma de hoja
ES2187822T3 (es) Comprimidos de disgregacion rapida.
ITRM930591A0 (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
AR024874A1 (es) Composiciones bactericidas
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
ES2173868T3 (es) Utilizacion de relaxina para la fabricacion de un medicamento destinado al tratamiento de enfermedades cardiovasculares.
HN2000000115A (es) Formulacion de sal comun y moxifloxacina
UY26456A1 (es) Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen.
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
AR039164A1 (es) Sales de venlafaxina de baja solubilidad en agua
SV2002000969A (es) Composicion parenteral reconstituible
AR010716A1 (es) Formulacion para tabletas efervecentes desinfectantes y metodo para formar una solucion desinfectante
AR036937A1 (es) Tableta masticable que contiene lisina
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
ES2169223T3 (es) Substancia anticancerosa que inhibe la metastasis cancerosa.
ES2101317T3 (es) Medicamento para aumentar el nivel de testosterona.
HK1046242A1 (en) Preparations for the application of anti-inflammatory agents.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120